Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Source: insidermonkey.com
Stay updated with breaking news from Brian Cheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.
Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.
The biotech firm could emerge as a key player treating autoimmune diseases, JPMorgan said.
Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.27. Roivant Sciences Ltd.